Name 3 signs/symptoms that meconium ileus and fibrosing colonopathy share. What is the major difference?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Name 3 signs/symptoms that meconium ileus and fibrosing colonopathy share. What is the major difference?

Explanation:
Both conditions manifest as obstruction within the digestive tract in people with cystic fibrosis. The three signs that fit this shared pattern are intestinal obstruction, a palpable mass in the right lower quadrant from dilated bowel with thickened contents, and abdominal pain. In meconium ileus, the RLQ mass is a classic finding due to a dilated ileum filled with inspissated meconium. The major difference lies in what causes the obstruction: fibrosing colonopathy arises from high-dose pancreatic enzyme therapy leading to fibrosis and narrowing of the colon, whereas meconium ileus is a congenital obstruction from thick, sticky meconium in the ileum and is not caused by enzyme therapy.

Both conditions manifest as obstruction within the digestive tract in people with cystic fibrosis. The three signs that fit this shared pattern are intestinal obstruction, a palpable mass in the right lower quadrant from dilated bowel with thickened contents, and abdominal pain. In meconium ileus, the RLQ mass is a classic finding due to a dilated ileum filled with inspissated meconium. The major difference lies in what causes the obstruction: fibrosing colonopathy arises from high-dose pancreatic enzyme therapy leading to fibrosis and narrowing of the colon, whereas meconium ileus is a congenital obstruction from thick, sticky meconium in the ileum and is not caused by enzyme therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy